D

Derma Internacional | Buenos Aires, Argentina

Research site

(Unclaimed)

Location

Virrey del Pino 2456, Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina

Site insights

Top conditions

Top treatments

Lebrikizumab

Rocatinlimab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis

The main objective of the study will be to evaluate the efficacy of rocatinlimab compared with placebo at week 24 on the patient-reported outcome (PR...

Active, not recruiting

Prurigo Nodularis

Drug: Placebo

Drug: Rocatinlimab

A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis (ADorable-1)

The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to \<18...

Active, not recruiting

Atopic Dermatitis

Eczema

Drug: Placebo

Drug: Lebrikizumab

Trial sponsors

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms